Search research articles
Contact Us
Filters
Showing results (201-210 of 279) with videos related to
Page
of 28
Sort By:
Neuro-Oncology Advances
|
July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop Proceedings
Brett J Theeler, Yamini Dalal, Michelle Monje, et al.
Neuro-Oncology
|
October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report
Elizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
The Journal of Pathology
|
May 19, 2023
Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion
Miriam Bornhorst, Augustine Eze, Surajit Bhattacharya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Lindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Mark W Kieran, Susan Chi, Stewart Goldman, et al.
Neurology. Genetics
|
August 11, 2021
Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1
Karin S Walsh, Pamela L Wolters, Brigitte C Widemann, et al.
NPJ Precision Oncology
|
September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
Erin R Bonner, Robin Harrington, Augustine Eze, et al.
Journal of Neuro-Oncology
|
June 5, 2025
Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments
Belinda Barton, Pamela L Wolters, Karin S Walsh, et al.
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Oncotarget
|
May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biology
Jerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Page
of 28
Search research articles
Search
Showing results (201-210 of 279) with videos related to
Sort By:
Page
of 28
Neuro-Oncology Advances
|
July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop Proceedings
Brett J Theeler, Yamini Dalal, Michelle Monje, et al.
Neuro-Oncology
|
October 11, 2017
Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report
Elizabeth M Wells, Nicole J Ullrich, Kristy Seidel, et al.
The Journal of Pathology
|
May 19, 2023
Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion
Miriam Bornhorst, Augustine Eze, Surajit Bhattacharya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Lindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Mark W Kieran, Susan Chi, Stewart Goldman, et al.
Neurology. Genetics
|
August 11, 2021
Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1
Karin S Walsh, Pamela L Wolters, Brigitte C Widemann, et al.
NPJ Precision Oncology
|
September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors
Erin R Bonner, Robin Harrington, Augustine Eze, et al.
Journal of Neuro-Oncology
|
June 5, 2025
Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments
Belinda Barton, Pamela L Wolters, Karin S Walsh, et al.
Journal of Neuro-Oncology
|
April 14, 2017
Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach
Taryn B Fay-McClymont, Danielle M Ploetz, Don Mabbott, et al.
Oncotarget
|
May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biology
Jerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Page
of 28